Last reviewed · How we verify
Vaginal gel HYALOGYN® — Competitive Intelligence Brief
marketed
Vaginal moisturizer/lubricant
Gynecology
Small molecule
Live · refreshed every 30 min
Target snapshot
Vaginal gel HYALOGYN® (Vaginal gel HYALOGYN®) — Ospedale Policlinico San Martino. HYALOGYN® is a hyaluronic acid-based vaginal gel that provides lubrication and hydration to restore vaginal moisture and elasticity.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vaginal gel HYALOGYN® TARGET | Vaginal gel HYALOGYN® | Ospedale Policlinico San Martino | marketed | Vaginal moisturizer/lubricant |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vaginal moisturizer/lubricant class)
- Ospedale Policlinico San Martino · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vaginal gel HYALOGYN® CI watch — RSS
- Vaginal gel HYALOGYN® CI watch — Atom
- Vaginal gel HYALOGYN® CI watch — JSON
- Vaginal gel HYALOGYN® alone — RSS
- Whole Vaginal moisturizer/lubricant class — RSS
Cite this brief
Drug Landscape (2026). Vaginal gel HYALOGYN® — Competitive Intelligence Brief. https://druglandscape.com/ci/vaginal-gel-hyalogyn. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab